Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Total Current Liabilities (2018 - 2025)

TELA Bio (TELA) has 8 years of Total Current Liabilities data on record, last reported at $17.0 million in Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 0.71% year-over-year to $17.0 million; the TTM value through Sep 2025 reached $17.0 million, up 0.71%, while the annual FY2024 figure was $15.6 million, 8.07% down from the prior year.
  • Total Current Liabilities reached $17.0 million in Q3 2025 per TELA's latest filing, down from $19.1 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $19.1 million in Q2 2025 and bottomed at $5.6 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $13.7 million, with a median of $15.0 million recorded in 2024.
  • Peak YoY movement for Total Current Liabilities: surged 117.91% in 2022, then dropped 8.07% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $10.6 million in 2021, then grew by 17.29% to $12.4 million in 2022, then soared by 36.8% to $17.0 million in 2023, then decreased by 8.07% to $15.6 million in 2024, then grew by 8.84% to $17.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Total Current Liabilities were $17.0 million in Q3 2025, $19.1 million in Q2 2025, and $16.5 million in Q1 2025.